术前甲状腺癌患者超声不确定淋巴结:恶性肿瘤风险及预测恶性的超声表现
本研究对284例甲状腺癌患者的348枚淋巴结行细针穿刺或粗针活检,按超声分类评估恶性风险:可能良性2.8%、不确定19.5%、可疑78.4%。对于超声不确定淋巴结,良恶性组间短径、长径及长短径比值均无显著差异。
要点
- 超声不确定淋巴结的恶性风险为19.5%,介于可能良性(2.8%)与可疑(78.4%)之间。
- 超声不确定淋巴结定义为无强回声门及门部血流且无任何可疑征象。
- 良性与转移性不确定淋巴结的短径、长径及长短径比值均无显著差异。
关键影像表现/征象
- 超声不确定淋巴结无强回声门及门部血流,且无任何可疑征象。
- 超声不确定淋巴结中良性与转移性组短径分别为3.9 mm与3.8 mm(p=0.619)。
- 超声不确定淋巴结中良性与转移性组长径分别为7.3 mm与7.3 mm(p=0.590)。
- 超声不确定淋巴结中良性与转移性组长短径比值分别为1.9与1.9(p=0.652)。
诊断标准与关键数值
- 超声可能良性淋巴结恶性风险为2.8%(2/72)。
- 超声不确定淋巴结恶性风险为19.5%(16/82),与可能良性组差异有统计学意义(p=0.002),与可疑组差异亦有统计学意义(p<0.001)。
- 超声可疑淋巴结恶性风险为78.4%(152/194)。
临床应用与阅片要点
- 术前评估中遇到超声不确定淋巴结时,应认识到其恶性风险居中(19.5%)。
- 不宜仅依据大小或长短径比值判断超声不确定淋巴结的良恶性。
- 作者认为,对于超声不确定淋巴结,应考虑手术策略和淋巴结大小等临床因素进行适当分诊。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: Proper management of lymph nodes (LNs) with ultrasonographic (US) indeterminate features in thyroid cancer patients remains elusive. We aimed to evaluate the malignancy risk and US findings predictive of malignancy for US indeterminate LNs in preoperative thyroid cancer patients through node-by-node correlation.
MATERIALS AND METHODS: A total of 348 LNs in 284 thyroid cancer patients, who underwent fine-needle aspiration or core-needle biopsy between December 2006 and June 2015, were included. We determined the malignancy risks for US probably benign, indeterminate, and suspicious categories. For US indeterminate LNs, which had neither echogenic hilum nor hilar vascularity in the absence of any suspicious finding, US findings were compared between benign and metastatic LNs using Mann-Whitney U test and Fisher's exact test.
RESULTS: US imaging diagnoses were probably benign in 20.7% (n = 72) cases, indeterminate in 23.6% (n = 82), and suspicious in 55.7% (n = 194). Malignancy risk of US indeterminate LNs (19.5% [16/82]) differed from those of the US probably benign (2.8% [2/72]) (p = 0.002) and US suspicious LNs (78.4% [152/194]) (p < 0.001). Among US indeterminate LNs, there were no significant differences in short, long, and long-to-short diameter (L/S) ratios between benign and metastatic LNs (3.9 vs. 3.8 mm, p = 0.619; 7.3 vs. 7.3 mm, p = 0.590; 1.9 vs. 1.9, p = 0.652).
CONCLUSION: US indeterminate LNs were frequently encountered during preoperative evaluation and had intermediate malignancy risk. Given the lack of discriminative power of size criteria and L/S ratio, clinical factors such as surgical strategy and node size should be considered for proper triage of US indeterminate LNs in thyroid cancer.
引用
- Yoo RE, Kim JH, Bae JM, et al. Ultrasonographic Indeterminate Lymph Nodes in Preoperative Thyroid Cancer Patients: Malignancy Risk and Ultrasonographic Findings Predictive of Malignancy. Korean J Radiol. 2020. PMID: 32323505. doi:10.3348/kjr.2019.0755
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。